,Topics,Questions
0,A statement that the study involves research,"Which of the following statements best reflects the nature of the activity described in the informed consent form?
A) The document is a contract for medical services.
B) The document is a brochure for a health and wellness program.
C) The document is a consent form for participation in a research study.
D) The document is a patient's medical history questionnaire.

Correct answer: C) The document is a consent form for participation in a research study."
1,An explanation of the purposes of the research,"What is the primary goal of the research study involving Xindilizumab for locally advanced head and neck tumors?
A) To compare the effectiveness of Xindilizumab with a placebo in improving hair growth; 
B) To assess the impact of Xindilizumab on the cognitive function of patients post-treatment; 
C) To evaluate the progression-free survival (PFS) and 1-year progression-free survival (PFS) in patients after radiotherapy and chemotherapy; 
D) To determine the best dietary practices for patients with head and neck tumors post-treatment.

Correct answer: C"
2,The expected duration of the subject's participation,"For how long is each participant expected to be involved in the Xindilizumab maintenance therapy study for locally advanced head and neck tumors after radiotherapy and chemotherapy?
A) 12 months; B) 18 months; C) 24 months; D) 36 months

Correct answer: D) 36 months"
3,Any additional costs to the subject that may result from participation in the research,"Which of the following statements is true regarding additional costs for subjects participating in the Xindilizumab study for locally advanced head and neck tumors?

A) Subjects will incur significant out-of-pocket expenses for the immunotherapy drugs used in the study.
B) Subjects will be charged for routine blood tests, liver and kidney function tests, and imaging examinations required by the study.
C) Subjects will receive compensation for blood collection and transportation, and will not be charged for any treatment-related costs if research causes harm.
D) Subjects must pay for the immunotherapy drugs if they choose to participate in the study.

Correct answer: C) Subjects will receive compensation for blood collection and transportation, and will not be charged for any treatment-related costs if research causes harm."
4,A description of the procedures to be followed,"Which of the following best describes the process for participants who are randomized to the experimental group in the study?

A) Participants in the experimental group will receive a placebo treatment and undergo routine blood tests every 4 cycles.
B) Participants in the experimental group will start treatment within one month after the end of radiotherapy and chemotherapy, receiving intravenous Xindilizumab every 21 days for up to 18 cycles or until disease progression.
C) Participants in the experimental group will be given oral medication daily and will have CT scans every 2 cycles to evaluate toxic side effects.
D) Participants in the experimental group will receive Xindilizumab as a one-time treatment at the beginning of the study and will be monitored through self-assessment questionnaires.

Correct answer: B) Participants in the experimental group will start treatment within one month after the end of radiotherapy and chemotherapy, receiving intravenous Xindilizumab every 21 days for up to 18 cycles or until disease progression."
5,The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject,"What will happen if you choose to withdraw from the study at any point?
A) You will be required to pay for any treatments received during the study; B) You will be barred from receiving any further medical care from the hospital; C) Your decision to withdraw will not affect your future medical care or benefits; D) You will have to provide a valid medical reason to be able to withdraw from the study.

Correct answer: C"
6,Identification of any procedures which are experimental,"Which of the following interventions is considered experimental in the study described in the new consent form?
A) Standard radiotherapy and chemotherapy for locally advanced head and neck tumors
B) Maintenance therapy with Xindilizumab based on peripheral blood CD8^+ T_EX detection after standard treatment
C) Routine blood tests, liver and kidney function tests, and myocardial enzyme spectrum every 2 cycles
D) CT scans every 4 cycles to evaluate toxic side effects and recurrence

Correct answer: B"
7,The approximate number of subjects involved in the study,"How many participants are planned to be enrolled in the Xindilizumab maintenance therapy study for locally advanced head and neck tumors?
A) 50; B) 104; C) 150; D) 200
Correct answer: B) 104"
8,A description of any reasonably foreseeable risks or discomforts to the subject,"Which of the following is a potential risk associated with participating in the Xindilizumab study for locally advanced head and neck tumors?
A) Increased risk of common cold symptoms
B) Development of immune-related adverse reactions such as hepatitis or colitis
C) Guaranteed improvement in quality of life
D) Immediate and complete cure of the tumor

Correct answer: B"
9,A description of any benefits to the subject or to others which may reasonably be expected from the research,"Which of the following is a potential personal benefit mentioned in the consent form for participants in the Xindilizumab study for locally advanced head and neck tumors after radiotherapy and chemotherapy?

A) Guaranteed cure for head and neck tumors
B) Improvement in objective response rate and potential survival benefits
C) Free lifetime supply of Xindilizumab
D) Immediate financial compensation for all medical expenses

Correct answer: B) Improvement in objective response rate and potential survival benefits"
10,"A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject","If you choose not to participate in the Xindilizumab study for locally advanced head and neck tumors, what are the alternative options available to you?
A) You may seek alternative experimental treatments not described in this study; 
B) You can continue to receive treatment according to the standard diagnosis and treatment plan or participate in other studies; 
C) You will be required to undergo surgery instead of radiotherapy and chemotherapy; 
D) No alternative treatments are available outside of this study.

Correct answer: B"
11,"A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained","Who is authorized to access your medical records as part of the confidentiality agreement in this study?
A) Only the participant and the research team; B) The participant, research team, ethics committee, monitoring and auditing personnel, and pharmaceutical management departments; C) Any hospital staff member; D) The general public

Correct answer: B) The participant, research team, ethics committee, monitoring and auditing personnel, and pharmaceutical management departments"
12,"For research involving more than minimal risk, an explanation as to whether any compensation, and an explanation as to whether any medical treatments are available, if injury occurs and, if so, what they consist of, or where further information may be obtained","What does the new consent form indicate about compensation and medical treatment if a participant is injured during the study?
A) Participants will receive free medical treatment for injuries directly related to the study.
B) Participants will be responsible for the cost of any medical treatment for injuries.
C) The study will provide compensation for time and travel, but not for injuries.
D) The study will strive for compensation for injuries according to relevant laws and regulations.

Correct answer: D"
13,"Research, Rights or Injury: An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject","If you experience an adverse event or injury related to the study, whom should you contact for assistance and potential compensation?

A) The Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine;
B) The principal investigator of the study;
C) The local pharmacy;
D) Your personal physician.

Correct answer: A) The Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine;"
14,"A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits, to which the subject is otherwise entitled","Which of the following statements is true regarding your participation in the Xindilizumab study for locally advanced head and neck tumors?

A) Participation in the study is mandatory once you sign the consent form.
B) You may face penalties or loss of medical benefits if you refuse to participate in the study.
C) You can voluntarily withdraw from the study at any time without any penalties or loss of benefits you are entitled to.
D) Withdrawing from the study will result in a reduction of your standard medical care.

Correct answer: C) You can voluntarily withdraw from the study at any time without any penalties or loss of benefits you are entitled to."
